Abbreviations {#nomen0010}
=============

αT

:   α−Tocopherol

API

:   Apigenin

C3S

:   Cyanidin 3−sambubioside

CoMFA

:   Comparative molecular field analysis

COP

:   Coptisine

EA

:   Ellagic acid

ECH

:   Echinacoside

KAEM

:   Kaempferol

Keap1

:   Kelch−like ECH−associated protein 1

L5G

:   Luteolin−5−O−glucoside

MAG

:   Magnoflorine

Nrf2

:   Nuclear factor erythroid 2−related factor 2

PIP

:   Piperine

PLS

:   Partial least squares

QSAR

:   Quantitative structure--activity relationship

RUT

:   Rutin

1. Introduction {#sec1}
===============

Oxidative stress, which is caused by an imbalance between reactive species and antioxidative stress defense systems in cells, plays a key role in many diseases, including cancers ([@bib21]), cardiovascular diseases ([@bib1]), neurodegenerative diseases ([@bib8]) et al. The nuclear factor erythroid 2−related factor 2 (Nrf2) pathway is the major pathway that responds to reactive species and redox potentials, and Nrf2 activation is a key defense mechanism against oxidative stress ([@bib2]). However, under physiological conditions, repressor Kelch−like ECH−associated protein 1 (Keap1) holds Nrf2 in the cytoplasm and promotes its ubiquitination ([@bib16]). By contrast, under pathological conditions, Nrf2 is released from Keap1, translocates to the nucleus, and triggers the transcriptional activation of ARE−dependent genes and antioxidative enzymes ([@bib7]). Thus, targeting the Nrf2--ARE signaling pathway is a logical strategy to discover therapeutic agents for diseases and conditions induced by oxidative stress. The direct inhibition of the Keap1--Nrf2 protein--protein interaction is an alternative for the discovery of small−molecule Nrf2 activators ([@bib14]). Compounds that interact with Keap1 and occupy the Nrf2 binding site in the protein can cause the dissociation of Keap1 from Nrf2 and finally induce the transcriptional activation of Nrf2 ([@bib19]).

Phytochemicals have significantly contributed to drug discovery. Many studies have shown that phytochemicals in edible flowers, vegetables, and fruits prevent or mitigate chronic diseases in humans ([@bib12]; [@bib23]). Studies in the last few decades have demonstrated the benefits of phytochemicals counteracting oxidative stress. Phenolic compounds as primary antioxidants can scavenge free radicals, thereby delaying or inhibiting the initiation step and interrupting the propagation step of lipid oxidation ([@bib11]). Vitamin E functions as a peroxyl radical−scavenging antioxidant and as an inhibitor of lipid peroxidation *in vitro* and *in vivo* ([@bib18]). Carotenoids can act as chemical quenchers undergoing irreversible oxygenation. Epidemiological studies and clinical trials showed that adequate carotenoid supplementation may significantly reduce the risk of several disorders mediated by reactive oxygen species ([@bib9]). Natural alkaloids are effective under oxidative stress in DPPH, FRAP, and TEAC assays ([@bib20]). Some of these natural compounds exhibit antioxidant effects through activating the Nrf2 pathway; however, details on this finding are few.

Molecular docking is widely used to predict the conformation of small−molecule ligands within the appropriate target binding site accurately ([@bib17]). Quantitative structure--activity relationship (QSAR) modeling is a well−used computer−aided drug design method because it can amalgamate statistics and computational chemistry as well as complement the experimental approach. Comparative molecular field analysis (CoMFA) ([@bib6]), which is a useful method in ligand−based drug design strategy, holds that appropriate sampling of steric and electrostatic fields around molecules provides information necessary for understanding their biological activities. Statistics is computed by partial least squares (PLS) regression analysis.

In this study, molecular docking and 3D−QSAR were applied to evaluate the interaction effects between 178 phytochemicals and the Nrf2 binding site in Keap1. Phenylethanoid glycosides showed better effects than other compounds. To verify the presumptive model above, 11 compounds from high−, medium−, and low−total−score groups were further studied on a H~2~O~2~−induced oxidative−injured cell model, and compounds from different groups showed significantly different activation effects on Nrf2.

2. Material and methods {#sec2}
=======================

2.1. Search for small molecules {#sec2.1}
-------------------------------

A search for phytochemicals was carried out using PubMed, Web of science, and Google Scholar. Keywords used for the search were "antioxidant" and "Nrf2 activators." Natural antioxidants were selected artificially according to the classification standard of phytochemicals. Then the 3D conformer of these phytochemicals were searched in PubChem. A compound library of 178 phytochemicals, whose 3D conformer could be found in PubChem, was created (Supplement [Table 1](#tbl1){ref-type="table"} ).Table 1Molecular docking results of different kinds of compounds with Keap1.Table 1ClassificationAverage Total_ScorePhenylethanoid glycosides7.3113Tocopherols6.2478Flavones5.0257Flavanols4.9119Anthocyanins4.8552Flavonols4.7565Stibenes4.5216Flavanones4.3529Chalcones4.3034Carotenoids3.9153Isoflavonoids3.4539Phenolic acids3.3291Quinones3.2318Coumarins3.1289Terpenes3.0130Alkaloids2.5660Organosulfurs1.9453Others1.8592

2.2. Chemical compounds and reagents {#sec2.2}
------------------------------------

Cyanidin 3−sambubioside (C3S; CAS no. 33012−73−6), luteolin−5−O−glucoside (L5G; CAS no. 20344−46−1), rutin (RUT; CAS no. 153−18−4), echinacoside (ECH; CAS no. 82854−37−3), apigenin (API; CAS no. 520−36−5), kaempferol (KAEM; 520−18−3), coptisine (COP; CAS no. 3486−66−6), magnoflorine (MAG; CAS no. 2141−09−5), and piperine (PIP; CAS no. 94−62−2) were purchased from Yuanye Biotechnology Company (Shanghai, China). α−Tocopherol (αT; CAS no. 10191−41−0), ellagic acid (EA; CAS no. 476−66−4), and H~2~O~2~ were obtained from Aladdin® (Shanghai, China). RPMI−1640 medium and fetal bovine serum were procured from Hyclone (Logan, Utah, USA), 0.5% trypsin EDTA, penicillin, and streptomycin were purchased from Keyi (Hangzhou, China). Antibodies to Nrf2, histone H3, and β−actin; anti−mouse−horseradish peroxide (HRP) IgG; and anti−rabbit--HRP--IgG were acquired from Abcam (London, UK). α−Tocopherol was used as a positive control.

2.3. Protein and ligand structure preparation {#sec2.3}
---------------------------------------------

Keap1 3D structure (Protein Data Bank (PDB) codes: 4l7b) was obtained from PDB and prepared with SYBYL X 2.0 ([@bib28]). A total of 178 phytochemicals that were proven to have good antioxidant properties were selected and prepared in accordance with the procedure in Section [2.1](#sec2.1){ref-type="sec"}. The SDF formats of their 3D structures were obtained from PubChem chemical library.

2.4. Docking calculations {#sec2.4}
-------------------------

The semi−flexible docking of natural compounds as ligands for Keap1 structures was evaluated using SYBYL X2.0. Surflex--Dock module of SYBYL is a molecular docking unit that performs flexible alignments. The results are presented as docking accuracy and screening utility ([@bib29]). The docking procedure was started with protomol generation using a ligand−based approach. For each protein--ligand pair, three top−ranked docked solutions were saved.

2.5. 3D−QSAR (CoMFA) studies {#sec2.5}
----------------------------

In consideration that the results of CoMFA studies are sensitive to the alignment of molecules, the alignment of 3D structures plays a vital role during CoMFA analysis. The lowest energy conformer of analog was chosen as a template structure for the molecular alignment of the data set. Molecules in their respective lowest energy conformations were superimposed on the template using the rigid−body fit option in SYBYL−X 2.0 ([@bib30]). Following the standard procedure, SYBYL−X 2.0 was used to create a database of 178 phytochemicals. The PLS algorithm was used to obtain the relationship between the structural parameters and the binding affinity. Cross−validation analysis was performed using the leave−one−out method, wherein 20 compounds were removed from the dataset and their activity were predicted using the model derived from the rest of the dataset. The cross−validated R2 that resulted in the optimum number of components and lowest standard error of prediction was selected ([@bib31]).

2.6. Cell culture {#sec2.6}
-----------------

Rat adrenal pheochromocytoma line (PC12 cells) was obtained from the Institute of Biochemistry and Cell Biology, SIBS (CAS, Shanghai, China). The cells were maintained in RPMI−1640 (Hyclone) containing 10% fetal bovine serum (Hyclone), 100 U/mL penicillin, and 0.1 mg/mL streptomycin at 37 °C with 5% CO2. The medium was changed every other day.

PC12 cells were seeded in 100 mm Petri dishes at 1 × 10^7^ cells/dish. After attachment, the cells were treated with the selected compounds (10 and 50 μM) for 24 h and then incubated with H~2~O~2~ for another 2 h with the previous compounds removed.

2.7. Cell viability assay {#sec2.7}
-------------------------

PC12 cells were seeded in 96-well plates at 2 × 10^4^ cells/well. After attachment, cells were incubated with tested compounds at 10 and 50 μM for 24 h. After incubation, cells were treated with 5 mg/mL MTT for 4 h at 37 °C. Then the media were carefully removed, the formazan crystals were dissolved in 150 μL of DMSO, the absorbance was measured at 570 nm on a plate reader. Controls utilized the same concentration of medium with DMSO alone. Cell viability was normalized as the percentage of control.

2.8. Western blot {#sec2.8}
-----------------

Cytosolic and nuclear proteins were isolated with a Beyotime kit. The growth medium was removed after cell culture, and the cells were washed twice using 1 mL of PBS, added with 1 mL of PBS, and then scraped into centrifuge tubes on ice. The cells were centrifuged at 1200×*g* for 5 min. The cells were added with Buffer A containing 1% PMSF on ice for 1 min, vortexed for 5 s, and then placed on ice for 20 min. Then, the cells were added with Buffer B, vortexed for 5 s, and then placed on ice for 1 min. The tubes were centrifuged at 12,000×*g* for 15 min at 4 °C, added with Buffer N containing 1% PMSF on ice for 30 min, vortexed every 2--3 min, and then centrifuged again at 14,000×*g* for 15 min at 4 °C. The protein concentration of the samples was detected by a Beyotime BCA protein assay kit, and all samples were stored at −80 °C for Western blot analysis. Western blot was performed using standard methods. In brief, protein samples (20--30 μg) were separated by SDS−PAGE and transferred onto PVDF membranes. The membranes were blocked in 5% milk−TBST and then incubated overnight at 4 °C in primary antibodies. Antibodies used included Nrf2 (Abcam), Histone H3 (Abcam), and β−actin (Abcam). Peroxidase−conjugated anti−mouse IgG (Abcam) or anti−rabbit IgG (Abcam) was used as the secondary antibody. Protein bands were visualized using ChemiScope series (Clinx Science Instruments, Shanghai, China). The gray value of protein bands was quantified using ImageJ (National Institutes of Health, Bethesda, Maryland, USA).

2.9. Statistical analysis {#sec2.9}
-------------------------

One−way ANOVA with LSD analyses was performed using SPSS. All results were confirmed from three independent experiments. Data were expressed as the means ± standard error of the mean. Data were considered significantly different at p \< 0.05.

3. Results {#sec3}
==========

3.1. Docking calculations using SYBYL {#sec3.1}
-------------------------------------

Keap1 3D structure was prepared with SYBYL X 2.0, and the binding pocket, which easily interacted with other compounds, was obtained ([Fig. 1](#fig1){ref-type="fig"} ). A library of 178 phytochemicals (Supplement [Table 1](#tbl1){ref-type="table"}) was prepared as mentioned in Section [2.1](#sec2.1){ref-type="sec"}. The 178 phytochemicals were divided into 18 varieties according to their structural features: alkaloids, anthocyanins, carotenoids, chalcones, coumarins, flavanols, flavanones, flavones, flavonols, isoflavonoids, organosulfurs, phenolic acids, phenylethanoid glycosides, quinones, stibenes, terpenes, tocopherols, and others.Fig. 1The binding pocket of Keap1.The green ribbon stands for the second structure of Keap1, the red region in the middle stands for the binding pocket that is easy to binding other compounds. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 1

According to the rule of SYBYL X 2.0, C_Score shows hydrogen bonding, metal-ligand interaction, lipophilic contact, and rotational entropy, along with an intercept term. Total_Score shows the binding affinity between the ligand and protein. When Total_Score \>6, the ligand is considered as a candidate for further study, meanwhile the C_Score ≥4, the candidate is considered to be more promising. Here Average Total_Score is the average value of Total_Score of all the compounds with similar structural features. This value shows the binding affinity between the different classification of compounds and protein, was used to compare the binding affinity with Keap1 of 18 varieties of compounds. Docking calculation results ([Table 1](#tbl1){ref-type="table"}) showed that their binding affinity with Keap1 in descending order was shown and the Average Total_Score were as follows: phenylethanoid glycosides \> tocopherols \> flavones \> flavanols \> anthocyanins \> flavonols \> stibenes \> flavanones \> chalcones \> carotenoids \> isoflavonoids \> phenolic acids \> quinones \> others \> coumarins \> terpenes \> alkaloids \> organosulfurs. These compounds could be divided into three groups, the high−total−score group (Average Total_Score \> 6), the medium−total−score group (6 \> Average Total_Score \> 3), and the low−total−score group (Average Total_Score \< 3).

As shown in [Table 2](#tbl2){ref-type="table"} , 24 compounds showed strong binding affinity with Keap1 and most of them have C_Score ≥4. The interactive amino acids including Y334, S363, L365, N382, S383, P384, D385, N414, I416, V463, S508, S555, L557, Y572, S602. The 3D structure of binding mode between Keap1 and the 24 compounds above were shown in Supplement [fig.1](#fig1){ref-type="fig"}.Table 224 compounds with potential interaction with Keap1.Table 2ClassificationPubChem CIDNameTotal_ScoreC_scoreInteractive Amino AcidsAnthocyanins441688Cyanidin 3,5-O-diglucoside7.65113Y334/S363/S508Anthocyanins6602304Cyanidin 3-sambubioside7.58144S363/S602/S555/N414Flavones5280704Apigenin 7-glucoside6.02615S363/S602Flavones5282150Apigenin 7-O-neohesperidoside6.70403Y334/S363/S383/P384/S602Flavones12304093Apigenin-7-O-glucoside7.91294Y334/S363Flavones9851181Apigenin-7-O-rutinoside8.00125S363/P384/D385/N414/S602Flavones15559460Luteolin-5-O-glucoside6.68925S363/N414/S602Flavonols5280805Rutin6.47474S363/S508/S602Flavonols5318645Isorhamnetin-3-O-glucoside6.28424S363/N414/S555/S602Flavonols17751019Isorhamnetin-3-O-rutinoside6.04383S363/N414/S508/S602Phenylethanoid glycosides5281771Echinacoside9.34024S363/P384/Y572Phenylethanoid glycosides16091519Ternstroside A8.91845S363/N414/S508/S555/S602Phenylethanoid glycosides16091522Ternstroside D8.65655S363/S602Phenylethanoid glycosides23958169Isoforsythoside A8.23344S508/S555/S602Phenylethanoid glycosides6476333Isoacteoside8.17764Y334/S555Phenylethanoid glycosides5281773Forsythiaside A8.10384L365/I416/V463/S602Phenylethanoid glycosides16091521Ternstroside C8.06853S363/N382/S383/D385/S508/Y572Phenylethanoid glycosides5281800Acteoside7.49715Y334/S363/N382/N414/I416/L557/S602Tocopherols92094δ-tocopherol6.97343S363Tocopherols14985α-tocopherol6.77593Y572Tocopherols92729γ-tocopherol6.77273S363Tocopherols5282347α-tocotrienol6.67254NoneTocopherols5282349γ-tocotrienol6.19562S555Tocopherols6857447β-tocopherol6.01035S363[^2]

3.2. Effects of glycosides and oxygen molecules on binding affinity with Keap1 {#sec3.2}
------------------------------------------------------------------------------

The 18 varieties of compounds were divided into two groups, the compounds containing glycosides (i.e., anthocyanins, flavanols, flavanones, flavones, flavonols, isoflavonoids, and phenylethanoid glycosides) and the compounds without glycosides (i.e., alkaloids, carotenoids, chalcones, coumarins, organosulfurs, phenolic acids, quinones, stibenes, terpenes, tocopherols, and others). The binding affinity with Keap1 of the compounds containing glycosides was better than the compounds without glycosides.

The number of glycosides was positively correlated with the binding affinity with Keap1. As shown in [Table 3](#tbl3){ref-type="table"} , phenylethanoid glycosides followed this typical pattern, and the binding affinity with Keap1 of phenylethanoid trisaccharides (ECH), phenylethanoid disaccharides (acteoside, isoacteoside), and phenylethanoid monosaccharides (salidroside) were in descending order. Compounds in [Table 4](#tbl4){ref-type="table"} also showed better binding affinity with Keap1 when they existed in the form of glycosides. The more glycosides these compounds combine with, the higher score they obtained.Table 3Molecular docking results of phenylethanoid glycosides.Table 3ClassificationPubChem CIDNameTotal_ScoreC_scoreStructural formulaPhenylethanoid trisaccharides5281771Echinacoside9.34024C~35~H~46~O~20~Phenylethanoid disaccharides6476333Isoacteoside8.17764C~29~H~36~O~15~5281800Acteoside7.49715C~29~H~36~O~15~Phenylethanoid monosaccharides159278Salidroside5.14432C~14~H~20~O~7~16091519Ternstroside A8.91845C~22~H~26~O~11~16091522Ternstroside D8.65655C~22~H~26~O~11~16091521Ternstroside C8.06853C~22~H~26~O~11~16091520Ternstroside B5.81484C~22~H~26~O~10~16091523Ternstroside E5.75593C~22~H~26~O~10~Table 4Molecular docking results of compounds that existed in the form of glycosides.Table 4ClassificationPubChem CIDNameTotal_ScoreC-scoreAnthocyanins128861Cyanidin4.10224441667Cyanidin 3-O-glucoside4.08424441674Cyanidin 3-O-rutinoside5.649846602304Cyanidin 3-sambubioside7.58144441688Cyanidin 3,5-O-diglucoside7.65113128853Delphinidin3.67984443650Delphinidin 3-O-glucoside5.0364410196837Delphinidin 3-sambubioside5.96784159287Malvidin4.44724443652Malvidin-3-glucoside2.55093441765Malvidin-3,5-diglucoside4.64952440832Pelargonidin3.82204443648Pelargonidin 3-O-glucoside4.96314441773Peonidin4.20314443654Peonidin 3-O-glucoside5.83223Flavonols5280863Kaempferol3.406025316673Kaempferol 3-rhamnoside3.312445282155Kaempferol 3-O-sophoroside4.008025282149Kaempferol-3-O-galactoside5.790735318767Kaempferol-3-O-rutinoside5.545055281672Myricetin4.985225491408Myricetin 3-galactoside3.723455352000Myricetin 3-rhamnoside5.831235280343Quercetin4.073745280804Quercetin 3-glucoside5.173335282166Quercetin 3-O-sophoroside5.288245487635Quercetin 3-sambubioside5.373445280805Quercetin 3-rutinoside6.47474439533Taxifolin3.54433119258Taxifolin 3-O-rhamnoside5.2025414282775Taxifolin 7-glucoside5.52503Flavanones440735Eriodictyol3.6048411541786Eriodictyol 7-O-sophoroside4.0434322524386Eriodictyol-7-O-glucoside5.6722483489Eriodictyol-7-O-rutinoside4.60354932Naringenin3.2582425075Naringenin 7-Rhamnoglucoside5.2218392794Naringenin-7-O-glucoside5.28674Flavones5280443Apigenin3.799435280704Apigenin 7-glucoside6.026155282150Apigenin 7-O-neohesperidoside6.7040312304093Apigenin-7-O-glucoside7.912949851181Apigenin-7-O-rutinoside8.001255280445Luteolin4.070245280637Luteolin 7-glucoside3.4014415559460Luteolin-5-O-glucoside6.68925

Meanwhile, the number of oxygen molecules was related to the binding affinity with Keap1. For example in [Table 3](#tbl3){ref-type="table"}, ternstroside A, ternstroside D, ternstroside C, ternstroside B, and ternstroside E were all phenylethanoid monosaccharides, and the only difference in their chemical formula was the number of oxygen molecules. Ternstroside A, ternstroside D, and ternstroside C contain 11 oxygens, whereas ternstroside B and ternstroside E contain 10 oxygens, which resulted in a significant difference in their binding affinity with Keap1: ternstroside A \> ternstroside D \> ternstroside C \> ternstroside B \> ternstroside E. The number of oxygen molecules was more sensitive than that of glycosides in predicting the binding affinity with Keap1.

3.3. QSAR between structure and their binding affinity with Keap1 {#sec3.3}
-----------------------------------------------------------------

In accordance with the method described in Section [2.5](#sec2.5){ref-type="sec"}, the relationship between the structural parameters and the binding affinity was evaluated by 3D CoMFA studies in the QSAR module in SYBYL−X 2.0. As shown in previous study, the *R* ^2^ \> 0.60 was satisfactory. The *R* ^2^ between the experimental and predicted values was 0.975, which indicates that the structure was a key element in binding to Keap1. The cross−validation analysis, wherein 20 compounds were randomly selected by the system, showed a good relationship between the structural parameters and the binding affinity. The plot of the actual versus predicted Total_Score values is shown in [Fig. 2](#fig2){ref-type="fig"} .Fig. 2Graph between actual Total_Score and predicted.Total_ScoreThe X axe: Total_Score is the true value from molecular docking. The Y axe: Predicted Total_Score is the virtual value from 3D CoMFA studies the blue spots stand for tested compounds, the red circle stand for phenylethanoid glycosides. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 2

3.4. Nrf2 activation effects of selected compounds {#sec3.4}
--------------------------------------------------

In the results above, 178 phytochemicals were divided into three groups depending on their binding affinity with Keap1. To evaluate their activation effect on Nrf2, 11 different compounds including C3S, L5G, RUT, API, KAEM, αT, COP, MAG, PIP, EA, and ECH from high−, medium−, and low−total−score groups were selected for further studied on a cell model.

The cytotoxicity assays was conducted at 10, 50, 100 μM, L5G, αT, and KAEM significantly reduced cell viability at 100 μM ([Fig. 3](#fig3){ref-type="fig"} ). So the compounds were tested at 10 or 50 μM in further study.Fig. 3Cytotoxicity study of tested 11 compounds on PC12 cells.Cell viability was detected by MTT assay. CK: control group, C3S: cyanidin 3-sambubioside treated group, L5G: luteolin-5-O-glucoside treated group, RUT: rutin treated group, API: apigenin treated group, KAEM: kaempferol treated group, αT: α-tocopherol treated group, COP: coptisine treated group, MAG: magnoflorine treated group, PIP: piperine treated group, EA: ellagic acid treated group, ECH: echinacoside treated group. \#*p* \< 0.05, versus control group, \#\#*p* \< 0.01, versus control group.Fig. 3

As shown in [Fig. 4](#fig4){ref-type="fig"} , the Nrf2 expression level in the nucleus increased after treatment with C3S, L5G, RUT, API, KAEM, αT, COP, MAG, PIP, EA, and ECH at 10 or 50 μM. Results of Western blot and gray density analyses showed that all of these tested compounds exerted no significant influence on Nrf2 expression in the cytosol ([Fig. 4](#fig4){ref-type="fig"}A and B) (*p* \> 0.05). C3S, L5G, RUT, αT, and ECH whose Total_Score were \>6 increased Nrf2 expression in the nucleus ([Fig. 4](#fig4){ref-type="fig"}C and D) (*p* \< 0.01), and their effect on Nrf2 activation in descending order is as follows: C3S (46.54%, 61.80%) \> αT (51.99%, 59.54%) \> L5G (26.47%, 42.46%) \> ECH (12.51%, 30.19%) \> RUT (16.69%, 18.21%). This order was consistent with their Total_Score value (except ECH). Meanwhile, API and KAEM from the medium−total−score group and COP, MAG, and PIP from the low−total−score group showed no effect on Nrf2 activation (except PIP at 50 μM). The results above indicated that the compounds showing potential binding affinity (Total_Score \> 6, C_score ≥ 4) with the Nrf2 binding site in Keap l can activate Nrf2 under oxidative stress.Fig. 4The influence of tested 11 compounds on Nrf2 expression both in cytoplasm and nucleus.PC12 cells were incubated with tested compounds (10 μM 50 μM) for 24 h, and then incubated with 200 μM H~2~O~2~ for another 2 h after the previous compounds removed. (A) The expression of Nrf2 protein in cytoplasm was detected by immunoblotting using specific antibody. β-Actin was used as loading control. (B) The quantitative densitometric analyses of Nrf2 protein in cytoplasm. (C) The expression of Nrf2 protein in nucleus was detected by immunoblotting using specific antibody. Histones H3 was used as loading control. (D) The quantitative densitometric analyses of Nrf2 protein in nucleus. All data are expressed as means ± SD and represent three independent experiments. CK: control group, Model: H~2~O~2~ treated group, C3S: cyanidin 3-sambubioside treated group, L5G: luteolin-5-O-glucoside treated group, RUT: rutin treated group, API: apigenin treated group, KAEM: kaempferol treated group, αT: α-tocopherol treated group, COP: coptisine treated group, MAG: magnoflorine treated group, PIP: piperine treated group, EA: ellagic acid treated group, ECH: echinacoside treated group. α−Tocopherol was used as a positive control. \#*p* \< 0.05, versus H~2~O~2~ treated group, \#\#*p* \< 0.01, versus H~2~O~2~ treated group.Fig. 4

4. Discussion {#sec4}
=============

In the present study, 178 phytochemicals were investigated to make sure whether they can effectively activate the transcription factor Nrf2 using molecular docking methods. The main findings of this study were as follows: (1) Structure of the compounds determined their inhibitory effect on the Keap1--Nrf2 protein--protein interaction. Compounds with abundant oxygen or glycosides effectively inhibited the Keap1--Nrf2 interaction. (2) The steric/acceptor/hydrophobic contribution instead of the electrostatic/donor contribution was the predominant element affecting the binding affinity. (3) Compounds with higher Total_Score (Total_Score \> 6) in binding affinity with Keap1 showed significantly positive effects on the nuclear translocation of Nrf2 in the H~2~O~2~−induced oxidative−injured cell model.

Molecular docking is a very powerful technique for screening large numbers of new compounds as active drug candidates, and this technique has been successfully used in the discovery of antimicrobial ([@bib22]), Alzheimer\'s disease related cyclophilin D inhibitors ([@bib26]), human coronavirus nucleocapsid protein inhibitors ([@bib4]). Previous studies paid great attention to antioxidants and Nrf2 activators; however, few of these studies systematically screened Nrf2 activators from known antioxidants. [@bib27] utilized AREc32 cells that contain a luciferase gene under the control of antioxidant response element promoters to screen Nrf2 activators. In this study, 178 phytochemicals were selected from the literature and directly explored whether they can activate Nrf2 by inhibiting the Keap1--Nrf2 protein--protein interaction using the molecular docking method. With the help of the software, 24 candidates were obtained, and the results showed that the number of glycosides and oxygen positively correlated with the binding affinity of compounds with Keap1. The procedure above was easy to operate and time saving.

Further study showed that the C3S, L5G, RUT, αT, and ECH from the 24 candidates can significantly increase the Nrf2 level in the nucleus. Several studies have reported about the antioxidant effects of αT ([@bib18]) and ECH ([@bib3]). [@bib15] reported that αT activates the transcription factor Nrf2 in neuronal cells and that ECH is a representative antioxidant compound in Herba Cistanches ([@bib25]). C3S ([@bib5]) was subjected to DPPH scavenging activities, AOP, and reducing power assessments; a dose−dependent antioxidant activity was observed. L5G ([@bib10]) in Korean milk thistle strongly protects t−BHP−treated HepG2 cells from oxidative damage, and these protective effects might be attributed to Nrf2 activation. RUT ([@bib24]) significantly attenuates oxidative stress and upregulates Nrf2 expression in a rat model. Previous studies are consistent with our results.

The 24 candidates bind with the special amino acids on Keap1, such as Ser363, Ser508, Ser555 and Ser602, which have been reported to be the key amino acids in the structure of the Keap1−Nrf2 interface ([@bib13]). The results indicated that the compounds with high binding affinity with Keap1 could directly inhibit Keap1−Nrf2 protein−protein interaction as Nrf2 activators.

5. Conclusion {#sec5}
=============

Antioxidants have the potential to activate Nrf2 by inhibiting the Keap1−Nrf2 protein−protein interaction, and the effect is largely determined by their structures. Compounds with abundant oxygen or glycosides can inhibit the Keap1−Nrf2 interaction more effectively and phenylethanoid glycosides showed the best effect among the 18 varieties. High−total−score group (Total_Score \> 6) show significant effects on the nuclear translocation of Nrf2 in H~2~O~2~−induced oxidative−injured cell model. These results may provide a new method for discovering Nrf2 activators that interfere with Keap1−Nrf2 protein−protein interaction.
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